NIH-funded research R01 grant

Depression and brain changes linked to memory decline in mild cognitive impairment

Official title: Clarifying the association of depressive symptoms with cortico-limbic tau, cerebral blood flow, neurodegeneration, and longitudinal cognitive decline in individuals with mild cognitive impairment

Funded at University of California, San Francisco · NIH-11317190 · Data updated 2026-11-12

This project looks at whether depression in people with mild cognitive impairment is tied to tau protein build-up, lower brain blood flow, and faster memory decline.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startApril 15, 2025
Project endMarch 31, 2030
Funding year2026
Award (this year)$1,977,456
NIH project number5R01AG091718-02
Project IDNIH-11317190 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are older adults diagnosed with mild cognitive impairment who have current or past depressive symptoms, including late-life major depression.

Less likely to help

People without cognitive impairment, younger adults, or those with no history of depressive symptoms are unlikely to receive direct benefit from this project.

What this research studies

If you have mild cognitive impairment, this project would enroll people with a range of depressive symptoms, from milder subsyndromal symptoms to late-life major depression. You would receive PET scans to measure tau in cortico-limbic brain regions, MRI scans to measure brain volume and cerebral blood flow, and repeated memory and thinking tests over time. The researchers will compare imaging results and cognitive changes to see if depression relates to more tau, reduced blood flow, and quicker cognitive decline. Visits and imaging are likely to occur at UCSF with longitudinal follow-up.

Why it matters

Potential benefit: If successful, this work could help explain why depression speeds memory loss and point to earlier detection methods or targeted treatments for people with MCI.

How similar studies have gone: Prior research suggests links between tau and depressive symptoms and between depression and cognitive decline, but most studies excluded people with major late-life depression, so this work addresses a gap rather than testing an already established approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Mackin, Robert Scott — University of California, San Francisco
  • Study coordinator: Mackin, Robert Scott

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.